Novel Psychoactive Substances (NPS) Testing

NPS:  12% Positivity Rate - Mitragynine remains prevalent

NPS_graph_2017_2.jpg
  • Mitragynine (Kratom) continues to be popular
  • Positivity rates of butylone, pentylone and alpha-PVP remain present in the market
  • N-ethlypentylone and furanyl fentanyl are among the top additional findings
  • Testing for Designer Opioids
  • Trending Novel Psychoactive Substances (NPS)
  • Additional Novel  Psychoactive Substances (NPS)
  • NMS Labs is actively adding newly emerging compounds, such as U-47700, 4-ANPP, and Furanyl Fentanyl. If any of these compounds are found in the testing process, NMS Labs may contact you to discuss additional testing options for your case.





Click here for most recent NPS trends report (updated August 2017)


Click here for most recent Novel Psychoactive Substances-Synthetic Cannabinoid


Click here for most recent Novel Psychoactive Substances-Synthetic Opioids


New Synthetic Cannabinoids:  Testing for JWH-018 alone is not enough.  Next generation compounds continue to dominate.

syn_can_graph_2017-(1).jpg





Click here for most recent Synthetic Cannabinoids trends report (updated August 2017)


PDF_icon2.jpg  Info Sheet

Additional resources: